Skip to content
The Policy VaultThe Policy Vault

Kineret — Cigna

Immunotherapy-Related Toxicities associated with CAR T-cell Therapy

Initial criteria

  • Medication is prescribed for a patient who has been or will be treated with a CAR T-cell therapy

Approval duration

1 month